104 related articles for article (PubMed ID: 16223488)
1. CCAAT/enhancer binding protein-beta (C/EBP-beta), a pivotal regulator of the TATA-less promoter in the rat catalase gene.
Taniguchi M; Hashimoto M; Hori N; Sato K
FEBS Lett; 2005 Oct; 579(25):5785-90. PubMed ID: 16223488
[TBL] [Abstract][Full Text] [Related]
2. Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcription.
Niehof M; Kubicka S; Zender L; Manns MP; Trautwein C
J Mol Biol; 2001 Jun; 309(4):855-68. PubMed ID: 11399064
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of the Xenopus CCAAT-enhancer binding protein beta gene promoter.
Foka P; Kousteni S; Ramji DP
Biochem Biophys Res Commun; 2001 Jul; 285(2):430-6. PubMed ID: 11444861
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M
J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302
[TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
7. C/EBP alpha and beta mimic retinoic acid activation of IGFBP-5 in neuroblastoma cells by a mechanism independent from binding to their site.
Cesi V; Giuffrida ML; Vitali R; Tanno B; Mancini C; Calabretta B; Raschellà G
Exp Cell Res; 2005 Apr; 305(1):179-89. PubMed ID: 15777798
[TBL] [Abstract][Full Text] [Related]
8. Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha.
Kita A; Yamasaki H; Kuwahara H; Moriuchi A; Fukushima K; Kobayashi M; Fukushima T; Takahashi R; Abiru N; Uotani S; Kawasaki E; Eguchi K
Biochem Biophys Res Commun; 2005 Jun; 331(2):484-90. PubMed ID: 15850785
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
10. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
Zha S; Isaacs WB
Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
[TBL] [Abstract][Full Text] [Related]
11. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
12. A transcriptional role for C/EBP beta in the neuronal response to axonal injury.
Nadeau S; Hein P; Fernandes KJ; Peterson AC; Miller FD
Mol Cell Neurosci; 2005 Aug; 29(4):525-35. PubMed ID: 15936952
[TBL] [Abstract][Full Text] [Related]
13. CCAAT enhancer binding protein beta and hepatocyte nuclear factor 3beta are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression.
Wöltje M; Tschöke B; von Bülow V; Westenfeld R; Denecke B; Gräber S; Jahnen-Dechent W
J Mol Endocrinol; 2006 Apr; 36(2):261-77. PubMed ID: 16595698
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional cooperation between NF-kappaB p50 and CCAAT/enhancer binding protein beta regulates Nur77 transcription in Leydig cells.
El-Asmar B; Giner XC; Tremblay JJ
J Mol Endocrinol; 2009 Feb; 42(2):131-8. PubMed ID: 18996961
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
[TBL] [Abstract][Full Text] [Related]
16. Discovery of transcriptional programs in cerebral ischemia by in silico promoter analysis.
Ridder DA; Bulashevska S; Chaitanya GV; Babu PP; Brors B; Eils R; Schneider A; Schwaninger M
Brain Res; 2009 May; 1272():3-13. PubMed ID: 19344698
[TBL] [Abstract][Full Text] [Related]
17. A role for CCAAT/enhancer-binding protein beta in the basal regulation of the distal-less 3 gene promoter in placental cells.
Holland MP; Bliss SP; Berghorn KA; Roberson MS
Endocrinology; 2004 Mar; 145(3):1096-105. PubMed ID: 14670999
[TBL] [Abstract][Full Text] [Related]
18. Odd-skipped related 2 gene transcription is regulated by CCAAT enhancer-binding protein delta in mesenchymal C3H10T1/2 cells.
Kawai S; Kato T; Sato M; Amano A
Genes Cells; 2006 Feb; 11(2):163-75. PubMed ID: 16436053
[TBL] [Abstract][Full Text] [Related]
19. The interaction of C-Rel with C/EBPbeta enhances C/EBPbeta binding to the C-reactive protein gene promoter.
Cha-Molstad H; Young DP; Kushner I; Samols D
Mol Immunol; 2007 Apr; 44(11):2933-42. PubMed ID: 17335903
[TBL] [Abstract][Full Text] [Related]
20. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]